Ayman Askari
Oswestry, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary.
Journal: Immunotherapy
Published: May 12, 2025
Real-World Effectiveness and Safety of SDZ ETN, an Etanercept Biosimilar, in Patients with Rheumatic Diseases: Final Results from Multi-Country COMPACT Study.
Journal: Advances in therapy
Published: June 22, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease.
Journal: BMC medicine
Published: September 06, 2022
Spontaneous Pneumothorax in a Patient with Systemic Lupus Erythematosus and Recent Infection with Coronavirus.
Journal: Case reports in pulmonology
Published: May 24, 2022
Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis.
Journal: Rheumatology (Oxford, England)
Published: January 07, 2016
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study.
Journal: Rheumatology (Oxford, England)
Published: August 16, 2014
Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis.
Journal: Journal of translational medicine
Published: March 06, 2014
Orphan receptor GPR15/BOB is up-regulated in rheumatoid arthritis.
Journal: Cytokine
Published: July 23, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026